4.5 Article Proceedings Paper

Integrin Signaling Through FAK in the Regulation of Mammary Stem Cells and Breast Cancer

期刊

IUBMB LIFE
卷 62, 期 4, 页码 268-276

出版社

WILEY
DOI: 10.1002/iub.303

关键词

FAK; mammary stem cells; signaling; mouse models

资金

  1. NCI NIH HHS [R01 CA150926] Funding Source: Medline
  2. NHLBI NIH HHS [R01 HL073394, R01 HL073394-07] Funding Source: Medline
  3. NIGMS NIH HHS [R01 GM052890, R01 GM052890-14, R01 GM048050, R01 GM048050-17] Funding Source: Medline

向作者/读者索取更多资源

Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase identified as a key mediator of intracellular signaling by integrins, a major family of cell surface receptors for extracellular matrix, in the regulation of different cellular functions in a variety of cells. Upon activation by integrins through disruption of an autoinhibitory mechanism, FAK undergoes autophosphorylation and forms a complex with Src and other cellular proteins to trigger downstream signaling through its kinase activity or scaffolding function. A number of integrins are identified as surface markers for mammary stem cells (MaSCs), and both integrins and FAK are found to play crucial roles in the maintenance of MaSCs in studies using mouse models, suggesting that integrin signaling through FAK may serve as a functional marker for MaSCs. Consistent with previous studies linking increased expression and activation of FAK to human breast cancer, these findings suggest a novel cellular mechanism of FAK promotion of mammary tumorigenesis by maintaining the pools of MaSCs as targets of oncogenic transformation. Furthermore, FAK inactivation in mouse models of breast cancer also reduced the pool of mammary cancer stem cells (MaCSCs), decreased their self-renewal in vitro, and compromised their tumorigenicity and maintenance in vivo, suggesting a potential role of integrin signaling through FAK in breast cancer growth and progression through its functions in MaCSCs. This review discusses these recent advances and future studies into the mechanism of integrin signaling through FAK in breast cancer through regulation of MaCSCs that may lead to development of novel therapies for this deadly disease. (C) 2010 IUBMB IUBMB Life, 62(4): 268-276, 2010

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据